Syncom Formula is not listed on NSE
52 Week HighSyncom Formula has hit a 52wk high of Rs 7.92 on BSE
AnnouncementsSyncom Formulations India: Updates on Outcome of AGM
AnnouncementsSyncom Formulations India: Outcome of AGM
100% of moneycontrol users recommend buying Syncom Formula.
What's your call on Syncom Formula today?
Read 41 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3229.00||0.68||3353.85||2420.00||55,011.13|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 830.00 93.02%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Syncom Formula is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 537.09 crore.The company has reported a consolidated sales of Rs 42.25 crore and a Net Profit of Rs 2.62 crore for the quarter ended Mar 2014.
The company management includes Kedarmal Bankda - Chairman, Vijay Bankda - Managing Director, Praveen Jindal - Director, Vinod Kumar Kabra - Director, Krishna Das Neema - Director.
It is listed on the BSE with a BSE Code of 524470.
Its Registered office is at 7, Niraj Industrial Estate, Off Mahakali Caves Road,,Andheri (East) Mumbai,Maharashtra - 400093.
Their Registrars are Ankit Consultancy Pvt. Ltd.